Inhibiting MiR-34a may be a future therapeutic approach, as adipocyte-to-macrophage delivery of MiR-34a inhibits Kruppel-like factor 4 (KLF4) expression, preventing M2 polarization and promoting obesity-induced insulin resistance (186). The gene discussed is KLF4; the disease is Obesity.